|
🐜
|
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
27 auth.
G. Goodwin,
P. Haddad,
I. Ferrier,
J. Aronson,
T. Barnes,
A. Cipriani,
D. Coghill,
S. Fazel,
J. Geddes,
H. Grunze,
E. Holmes,
O. Howes,
S. Hudson,
N. Hunt,
I. Jones,
...
I. Macmillan,
H. McAllister-Williams,
D. R. Miklowitz,
R. Morriss,
M. Munafo,
C. Paton,
B. J. Saharkian,
K. Saunders,
J. Sinclair,
D. Taylor,
E. Vieta,
A. Young
|
9 |
2009 |
9
🐜
|
|
🐬
|
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
J. Tiihonen,
J. Haukka,
Mark Taylor,
P. Haddad,
Maxine X. Patel,
P. Korhonen
|
9 |
2011 |
9
🐬
|
|
🐜
|
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
19 auth.
A. Cleare,
C. Pariante,
A. H. Young,
I. Anderson,
D. Christmas,
P. Cowen,
C. Dickens,
I. Ferrier,
J. Geddes,
S. Gilbody,
...
P. Haddad,
C. Katona,
G. Lewis,
A. Malizia,
R. H. McAllister-Williams,
P. Ramchandani,
Jan Scott,
David Taylor,
R. Uher
|
9 |
2015 |
9
🐜
|
|
🐜
|
Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence
19 auth.
V. Nunes,
J. Neilson,
N. O’Flynn,
N. Calvert,
S. Kuntze,
H. Smithson,
J. Benson,
J. Blair,
A. Bowser,
W. Clyne,
...
P. Crome,
P. Haddad,
S. Hemingway,
R. Horne,
S. Johnson,
S. Kelly,
B. Packam,
Mahendra Patel,
Jo Steel
|
9 |
2009 |
9
🐜
|
|
🐢
|
Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
D. Novick,
J. Haro,
D. Suarez,
V. Pérez,
R. Dittmann,
P. Haddad
|
8 |
2010 |
8
🐢
|
|
🐢
|
Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
D. Novick,
J. Haro,
D. Suarez,
V. Pérez,
R. Dittmann,
P. Haddad
|
8 |
2010 |
8
🐢
|
|
🦁
|
Adverse Effects of Atypical Antipsychotics
P. Haddad,
Sonu Sharma
|
8 |
2007 |
8
🦁
|
|
🐜
|
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
7 auth.
C. Correll,
L. Citrome,
P. Haddad,
J. Lauriello,
M. Olfson,
Stephen M Calloway,
...
J. Kane
|
8 |
2016 |
8
🐜
|
|
🦁
|
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
P. Haddad,
I. Anderson
|
8 |
2012 |
8
🦁
|
|
🐜
|
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
14 auth.
S. Cooper,
G. Reynolds,
T. Barnes,
E. England,
P. Haddad,
A. Heald,
R. Holt,
A. Lingford-Hughes,
David L. Osborn,
O. O. McGowan,
...
Maxine X. Patel,
C. Paton,
P. Reid,
D. Shiers
|
7 |
2016 |
7
🐜
|
|
🦁
|
Antidepressant Discontinuation Syndromes
P. Haddad
|
7 |
2001 |
7
🦁
|
|
🐜
|
The size, burden and cost of disorders of the brain in the UK
11 auth.
N. Fineberg,
P. Haddad,
L. Carpenter,
B. Gannon,
R. Sharpe,
A. Young,
...
E. Joyce,
J. Rowe,
D. Wellsted,
D. Nutt,
B. Sahakian
|
7 |
2013 |
7
🐜
|
